Ent-7α-acetoxytrachyloban-18-oic acid and ent-7α-hydroxytrachyloban-18-oic acid from Xylopia langsdorfiana A. St-Hil. & Tul. modulate K+ and Ca2+ channels to reduce cytosolic calcium concentration on guinea pig ileum  by Santos, Rosimeire F. et al.
European Journal of Pharmacology 678 (2012) 39–47
Contents lists available at SciVerse ScienceDirect
European Journal of Pharmacology
j ourna l homepage: www.e lsev ie r .com/ locate /e jpharPulmonary, Gastrointestinal and Urogenital Pharmacology
Ent-7α-acetoxytrachyloban-18-oic acid and ent-7α-hydroxytrachyloban-18-oic acid
from Xylopia langsdorﬁana A. St-Hil. & Tul. modulate K+ and Ca2+ channels to reduce
cytosolic calcium concentration on guinea pig ileum
Rosimeire F. Santos a, Italo R.R. Martins b, Rafael A. Travassos b, Josean F. Tavares b,c, Marcelo S. Silva b,c,
Edgar J. Paredes-Gamero d, Alice T. Ferreira d, Viviane L.A. Nouailhetas d, Jeannine Aboulaﬁa d,
Vera L.S. Rigoni d, Bagnólia A. da Silva b,c,⁎
a Departamento de Bioquímica e Farmacologia, Universidade Federal do Piauí (UFPI), Teresina, Piauí, Brazil
b Laboratório de Tecnologia Farmacêutica “Prof. Delby Fernandes de Medeiros”, Universidade Federal da Paraíba (UFPB), João Pessoa, Paraíba, Brazil
c Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba (UFPB), João Pessoa, Paraíba, Brazil
d Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brazil⁎ Corresponding author at: Universidade Federal da P
gia Farmacêutica “Prof. Delby Fernandes de Medeiros
Postal: 5009, CEP: 58051–970, João Pessoa, Paraíba, B
fax: +55 83 32167502.
E-mail addresses: bagnolia@ltf.ufpb.br, bagnoliasilva
0014-2999 © 2011 Published by Elsevier B.V.
doi:10.1016/j.ejphar.2011.12.028
Open accea b s t r a c ta r t i c l e i n f oArticle history:
Received 30 September 2011
Received in revised form 15 December 2011
Accepted 17 December 2011
Available online 27 December 2011
Keywords:
Intestinal smooth muscle
Spasmolytic activity
Diterpene
Xylopia langsdorﬁana
Ionic channels
CalciumIn this study we investigated the mechanism underlying the spasmolytic action of ent-7α-acetoxytrachylo-
ban-18-oic acid (trachylobane-360) and ent-7α-hydroxytrachyloban-18-oic acid (trachylobane-318), diter-
penes obtained from Xylopia langsdorﬁana, on guinea pig ileum. Both compounds inhibited histamine-
induced cumulative contractions (slope=3.5±0.9 and 4.4±0.7) that suggests a noncompetitive antagonism
to histaminergic receptors. CaCl2-induced contractions were nonparallelly and concentration-dependently re-
duced by both diterpenes, indicating blockade of calcium inﬂux through voltage-dependent calcium channels
(Cav). The Cav participation was conﬁrmed since both trachylobanes equipotently relaxed ileum pre-
contracted with S-(−)-Bay K8644 (EC50=3.5±0.7×10−5 and 1.1±0.2×10−5 M) and KCl (EC50=5.5±
0.3×10−5 and 1.4±0.2×10−5 M). K+ channels participation was conﬁrmed since diterpene-induced relax-
ation curves were signiﬁcantly shifted to right in the presence of 5 mM tetraethylammonium (TEA+)
(EC50=0.5±0.04×10−4 and 2.0±0.5×10−5 M). ATP-sensitive K+ channel (KATP), voltage activated K+
channels (KV), small conductance calcium-activated K+ channels (SKCa) or big conductance calcium-
activated K+ channels (BKCa) did not seem to participate of trachylobane-360 spasmolytic action. However
trachylobane-318 modulated positively KATP, KV and SKCa (EC50=1.1±0.3×10−5, 0.7±0.2×10−5 and 0.7±
0.2×10−5 M), but not BKCa. A ﬂuorescence analysis technique conﬁrmed the decrease of cytosolic calcium con-
centration ([Ca2+]c) induced by both trachylobanes in ileal myocytes. In conclusion, trachylobane-360 and
trachylobane-318 induced spasmolytic activity by K+ channel positive modulation and Ca2+ channel blockade,
which results in [Ca2+]c reduction at cellular level leading to smooth muscle relaxation.
© 2011 Published by Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The genus Xylopia is reported in Brazil for its ethnomedicinal and
pharmacological uses as diuretic and in skin conditions (Takahashi
et al., 2006), antibiotic (Lima et al., 2006) and hypotensive activity
(Nascimento et al., 2006). Several natural products were obtained
from Xylopia species including diterpenes (Campos de Andrade
et al., 2004), sesquiterpenes (Moreira et al., 2007), alkaloids (Silva
et al., 2009) and ﬂavonoids (Vega et al., 2007).araíba, Laboratório de Tecnolo-
”, Cidade Universitária, Caixa
razil. Tel.: +55 83 32167126;
@yahoo.com (B.A. da Silva).
ss under the Elsevier OA license.Xylopia langsdorﬁana A. St-Hil. & Tul. (Annonaceae), a tree mea-
suring between 5 and 7 m in height, is popularly known in Northeast
Brazil as “pimenteira da terra”. Some secondary metabolites as alka-
loids, ﬂavonoids and diterpenes (Silva et al., 2009; Tavares et al.,
2006) were isolated from it. The diterpenes are compounds biologi-
cally poorly studied, showing activity as cytotoxic to tumor cell lines
(Castello-Branco et al., 2009), antimicrobial (Li et al., 2005) and
osteoclastogenesis blockers (Pan et al., 2006). Moreover, some diter-
penes have shown hypotensive activity (Martinsen et al., 2010;
Oliveira et al., 2006) and relaxant effect in isolated guinea pig trachea
(Ribeiro et al., 2007).
Ent-7α-acetoxytrachyloban-18-oic acid (trachylobane-360) and
ent-7α-hydroxytrachyloban-18-oic acid (trachylobane-318) are tra-
chylobanes, a rare class of diterpene, isolated from the hexane
phase of crude ethanolic extract of X. langsdorﬁana stem bark. These
natural products were studied about their possible spasmolytic
40 R.F. Santos et al. / European Journal of Pharmacology 678 (2012) 39–47activity and we observed that both trachylobanes were unable to
exert spasmolytic action in male rat aorta or rat uterus, only
trachylobane-318 relaxed guinea pig trachea and, interestingly, both
compounds signiﬁcantly and concentration-dependently inhibited
contractions and relaxed pre-contracted guinea pig ileum (Santos
et al., 2011).
Natural product preparations have historically been the major
source of pharmaceutical agents. These products have pointed the
way to the future, contributing with many signiﬁcant advances in sci-
ence and industry, which inspired the pursuit of recapturing their
value (McChesney et al., 2007). Thus, in search for substances with
potential therapeutic use for treating intestinal smooth muscle disor-
ders, we aimed to elucidate the mechanisms underlying the spasmo-
lytic action of trachylobane-360 and trachylobane-318 on guinea pig
ileum.
2. Materials and methods
2.1. Plant material
Stems of X. langsdorﬁana A. St-Hil. & Tul. were collected in Cruz do
Espírito Santo municipality, Paraíba, Brazil, in July 2002. The plant
material was identiﬁed by Prof. Maria de Fátima Agra, head of the
Botany Section of the Laboratório de Tecnologia Farmacêutica Prof.
Delby Fernandes de Medeiros (LTF). A voucher specimen (AGRA
5541) is deposited at the herbarium Prof. Lauro Pires Xavier (JPB) of
the Universidade Federal da Paraíba (UFPB).
2.2. Isolation
Dried stems of X. langsdorﬁana (4 kg) were exhaustively extracted
with 95% ethanol. The solvent was evaporated to yield a dark syrup
(60 g), which was successively partitioned with hexane, chloroform
and ethyl acetate to yield 20, 16, and 12 g of crude residue, respec-
tively. The hexane fraction was subjected to column chromatographic
separation using hexane and hexane with increasing amounts of ethyl
acetate as eluents and monitored with thin layer chromatography
(TLC). Altogether, 95 fractions of 100 ml each were collected and dis-
tributed in 12 fractions (F-1–F-12). Fraction F-1 was recrystallized
frommethanol, yielding 1 (300 mg). Fraction F-4 was puriﬁed by pre-
parative TLC with ethyl acetate–hexane (9:1) as developer to obtain
compound 2 (56 mg). 1 and 2 were identiﬁed according to
1
H and
13
C nuclear magnetic resonance (NMR) data in spectral and chemi-
cal/physical comparison with data reported in literature. Thus, 1
was identiﬁed as trachylobane-360 (ent-7α-acetoxytrachyloban-18-
oic acid) and 2 was identiﬁed as trachylobane-318 (ent-7α-hydroxy-
trachyloban-18-oic acid) (Fig. 1). Identiﬁcation and NMR signal as-
signment were supported by the analysis of
13
C DEPT,
1
H–
1
H COSY,
HMQC, HMBC data and are described in literature by Tavares et al.
(2006).Fig. 1. Chemical structures of ent-7α-acetoxytrachyloban-18-oic acid (trachylobane-360)
(1) and ent-7α-hidroxitrachyloban-18-oic acid (trachylobane-318) (2).2.3. Solutions and drugs
Trachylobane-360 and trachylobane-318 were dissolved in Cremo-
phor® and diluted in distilledwater. In functional experiments, potassium
chloride (KCl), hydrochloric acid (HCl), histamine dihydrochloride, apa-
min, tetraethylammonium chloride (TEA+), 4-aminopyridine (4-AP), am-
inophylline, iberiotoxin and Cremophor® were dissolved and diluted in
distilledwater, while arachidonic acid (AA), S-(−)-Bay K8644 and gliben-
clamidewere dissolved in ethanol and diluted in distilledwater. The phys-
iological solution was a freshly modiﬁed Krebs solution (pH 7.4) with the
following composition (mM): NaCl (117.0), KCl (4.7), MgSO4 (1.3),
NaH2PO4 (1.2), CaCl2 (2.5), glucose (11.0) and NaHCO3 (25.0). A high K+
isosmotic solution (pH 7.4) of the following composition was also used:
NaCl (51.7), KCl (70.0), MgSO4 (1.3), NaH2PO4 (1.2), glucose (11.0) and
NaHCO3 (25.0). Concentrations are presented as ﬁnal concentration in
the bath solution after dissolving the pure substances directly into Krebs
solution. In cellular experiments were used bovine fetal serum, Dulbecco's
modiﬁed eagle medium (DMEM), penicillin, glutamine and trypsin/EDTA
solution (1:250). Drugs were purchased from Sigma Aldrich, Reagen (Rio
de Janeiro, RJ, Brazil), Cultilab (Campinas, SP, Brazil) and Vetec (Rio de
Janeiro, RJ, Brazil).
2.4. Animals
Adult guinea pigs (Cavia porcellus) of both sexes from bioterium
Prof. Thomas George of LTF/UFPB weighing 300–500 g were used.
The animals had free access to food and water, were kept in rooms
at 21±1 °C submitted to a 12-h light–dark cycle and fasted for 18 h
before the experiments. Actions on reducing pain, stress and any suf-
fering were taken in accordance with the ethical guidelines for animal
usage. All experimental procedures were previously approved and
performed in accordance with the Animal Research Ethic Committee
of LTF/UFPB guidelines (protocol CEPA 0101/08).
2.5. Measurement of ileum contractile activity
Guinea pigs were euthanized by cervical dislocation and exsangui-
nation, the ileum being immediately removed, cleaned of adhering fat
and connective tissue, immersed in physiological solution at room
temperature and continuously gassed with carbogen mixture (95%
O2 and 5% CO2). The longitudinal ileum layer was suspended in 5 ml
organ baths under resting load of 1.0 g at 37 °C. Isotonic contractions
were recorded using isotonic levers coupled to kymographs and
smoked drums (DTF, Brazil). An isometric transducer (FORT-10)
coupled to an ampliﬁer (TMB4M), both from World Precision Instru-
ments (EUA), connected to an analog/digital converter board (Bio-
data-Brazil) installed in computer with BioMed© software version
RV2 were used to record isometric contractions. Tissues were allowed
to stabilize for 30 min. The reversal of trachylobane-360 and
trachylobane-318 spasmolytic effect was analyzed by their removal
of strip organ bath then physiological solution was added, after
60 min a new contraction was induced and we observed that ileum
responsiveness was not altered by trachylobanes (data not shown).
2.6. Cell culture
Guinea pig ileum was collected as described earlier. The longitudi-
nal smooth muscle layer was carefully stripped off and the pieces
placed in warmed physiological solution. The organ was successively
washed with solution without Ca2+ and enriched with penicillin. Af-
terwards, tissue samples were placed in sterile culture bottles, to
which was added 5 ml of DMEM culture medium supplemented
with glutamine and 10% bovine fetal serum, and stored in CO2 incuba-
tor. After 24 h, 5 ml of culture medium was added to the bottles
(Chamley-Campbell et al., 1979). Each 48 h the bottles were washed
with PBS and the culture medium was replaced. When the bottles
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2 min in incubator and the bottles were resuspended in culture medi-
um and transferred to Falcon™ tubes for centrifugation (450×g) for
5 min. The supernatant was discarded and the pellets formed were
used in the experiments. All procedures were performed in aseptic
environment using laminar ﬂow cabinet.
2.7. Experimental protocols
2.7.1. Effect of trachylobane-360 and trachylobane-318 on histamine-induced
cumulative contractions
After stabilization, two similar cumulative concentration–response
curves for histamine were induced and diterpenes were incubated, in
different preparations, in the absence of histamine for 15 min in dif-
ferent concentrations as independent experiments. Afterwards, a
new histamine cumulative curve was obtained in presence of each
compound (3×10−5, 10−4 and 3×10−4 M). The average amplitude
of concentration–response curves for histamine was considered to
be 100% (control) and all contractions were assessed referring to it.
Each preparation was exposed to only one diterpene concentration.
The antagonism exerted by diterpenes was evaluated based on an
analysis of the Schild plot and their potencies with pD′2 values,
which is deﬁned as the negative logarithm to base 10 ofmolar concen-
tration values of an antagonist that reduces the response to an agonist
to 50% of its maximum effect (Emax), assessed through concentration–
response curves in both absence (control) and presence of diterpenes
(Dunne, 1979).
2.7.2. Effect of trachylobane-360 and trachylobane-318 on CaCl2-induced
contractions in depolarizing nominally Ca2+-free medium
After the stabilization period, the modiﬁed Krebs solution was
replaced by a depolarizing (with 40 mM KCl in equimolar exchange
for NaCl) and nominally Ca2+-free solution for 45 min. Two similar
CaCl2 cumulative concentration–response curves were induced and
diterpenes were incubated (3×10−5, 10−4 and 3×10−4 M), in dif-
ferent preparations, in the absence of CaCl2 for 15 min and a third
CaCl2 cumulative curve was obtained in the presence of each com-
pound. The maximal contraction obtained with the ﬁrst CaCl2 concen-
tration–response curve was considered to be 100% (control), and all
contractions were assessed referring to it. Each preparation was ex-
posed to a single diterpene concentration.
2.7.3. Effect of trachylobane-360 and trachylobane-318 on S-(−)-Bay
K8644-induced tonic contractions
After the stabilization period, the ileum was partially depolarized
by adding 15 mM KCl for 10 min (Usowicz et al., 1995) and a contrac-
tion was induced by 3×10−7 M S-(−)-Bay K8644, a selective
voltage-dependent calcium channel (Cav) agonist to L-type or CaV1
(Ferrante et al., 1989). In the sustained tonic phase of the contraction,
each diterpene was added cumulatively (10−7-3×10−4 M), in differ-
ent preparations, in order to obtain a relaxation curve. The relaxation
was expressed as the reversal percentage of initial contraction elicited
by contractile agents. The molar concentration of an agonist that pro-
duces 50% of its maximal effect (EC50) values was expressed as mean
and S.E.M. of EC50 individual values assessed through nonlinear
regression.
2.7.4. Effect of trachylobane-360 and trachylobane-318 on histamine-induced
tonic contractions in both presence and absence of non-selective potassium
channel blocker (TEA+ 5mM)
After appropriate stabilization of the preparations, tonic contrac-
tions were obtained by addition of 10−6 M histamine, and
trachylobane-360 and trachylobane-318 were cumulatively added
(10−8–3×10−4 M), in different preparations, to obtain a relaxation
curve (control). Afterwards, preparations were washed out and
TEA+ 5 mM, a non-selective potassium channel blocker (Latorreet al., 1989), was added to the preparations for 20 min. Then, other
tonic contractions were elicited in the presence of the blocker and
trachylobanes were cumulatively added independently. The relaxant
potency of the diterpenes was evaluated by comparing EC50 values
in both the absence and presence of the blocker.
2.7.5. Effect of trachylobane-360 and trachylobane-318 on histamine-induced
tonic contractions in bothpresence andabsence of selective potassiumchannel
blockers (glibenclamide, apamin, 4-AP, TEA+ 1mM or IbTx)
Histamine-induced tonic contractions were obtained as described
earlier.** Afterwards, the selective potassium channel blockers were
added to preparations for 20 min. Glibenclamide (10−5 M), a blocker
of ATP-sensitive K+ channels (KATP) (Sun and Benishin, 1994); apa-
min (10−7 M), a blocker of small conductance calcium-activated K+
channels (SKCa) (Ishii et al., 1997); 4-AP (3×10−7 M), a non-
selective blocker of voltage-activated K+ channels (Kv) (Robertson
and Nelson, 1994); TEA+ 1 mM, a speciﬁc blocker of big conductance
calcium-activated K+ channels (BKCa) (Knot et al., 1996) and iberio-
toxin (10−7 M) (IbTx), a selective blocker of the BKCa (Aboulaﬁa
et al., 2002), were added in different preparations. Other tonic con-
tractions were elicited in their presence and trachylobanes were cu-
mulatively added independently (10−8 - 3×10−4 M). Diterpene
relaxation potency was evaluated by comparing EC50 valuesin both
absence and presence of each blocker.
2.7.6. Effect of trachylobane-360and trachylobane-318onhistamine-induced
tonic contractions in both presence and absence of non-selective
phosphodiesterase inhibitor (aminophylline)
Histamine-induced tonic contractions were obtained as described
earlier. Then, aminophylline (10−4 M), a non-selective phosphodies-
terase inhibitor (Hirsh et al., 2004), was added to organ baths for 20
min and tonic contractions were induced in the presence of the inhib-
itor and trachylobanes were cumulatively added (10−9- 3×10−4 M),
in different preparations. The relaxation potency of each diterpene
was evaluated by comparing EC50 valuesin both absence and presence
of aminophylline.
2.7.7. Effect of trachylobane-360 and trachylobane-318 on cytosolic calcium
concentration of myocytes isolated from ileum longitudinal layer
Homogenized pellets with culture medium were cultured in black
96-well microplates, approximately 40.000 cells per well, and stabi-
lized in incubator for 24 h for cell adhesion. After the adherence peri-
od, the culture medium of each well was discarded and 50 μL Fluo-4
Direct Calcium Assay Kit, according to the manufacturer's instructions
(Molecular Probes/Invitrogen, USA), was added and let rest for 1 h at
37 °C in CO2 incubator, protected from light. Fluo-4 is a high-afﬁnity
calcium indicator that ﬂuoresces when excited at 488 nm and, even
in low concentrations, can almost double the ﬂuorescence of other
dyes, which is valuable in low density plated cell lines (Paredes
et al., 2008). After incorporating ﬂuorophore, the ﬂuorescence was
quantiﬁed in a FlexStation 3 microplate reader using the Soft Max
Pro software (Molecular Devices, USA). The Fluo-4 was excited at
490 nm, and light emission was detected at 525 nm. Records were
obtained without interruption for 3 min. The ﬂuorescence intensity
was increased by adding 10−6 M histamine (control) and later
3×10−5 M trachylobane-360 or trachylobane-318was added, in differ-
ent experiments, to assess the diterpene action in modify the [Ca2+]c.
2.8. Statistical analysis
Data are expressed as means and S.E.M. EC50 and IC50 values were
determinedwith nonlinear regression (Neubig et al., 2003). Differences
between means were statistically compared using Student's t-test and/
or one-way ANOVA followed by Bonferroni correction when appropri-
ate. The signiﬁcance level considered in all tests was 0.05. All values
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ware Inc., USA).
3. Results
3.1. Effect of trachylobane-360 and trachylobane-318 on histamine-induced
cumulative contractions
Trachylobane-360 and trachylobane-318 (3×10−5, 10−4 and
3×10−4 M) concentration-dependently inhibited histamine-induced
cumulative contractions shifting the curves nonparallelly to the right,
with Emax reduction (Fig. 2A and B). Slope values were 3.5±0.9 and
4.4±0.7 to trachylobane-360 and trachylobane-318, respectively,
which suggests noncompetitive antagonism. The relaxation potency
expressed as pD′2 was 4.1±0.3 and 4.7±0.06 to trachylobane-360
and trachylobane-318, respectively, which shows equipotency in inhi-
biting histamine-induced contractions since these values did not differ
statistically.
3.2. Effect of trachylobane-360 and trachylobane-318 on CaCl2-induced
contractions in depolarizing nominally Ca2+-free medium
Both trachylobanes (3×10−5, 10−4 and 3×10−4 M)
concentration-dependently inhibited Ca2+-induced contractions in
Ca2+-free depolarizing medium (Fig. 3A and B). CaCl2 cumulative
concentration–response curves were nonparallelly shifted to the
right and Emax reduced from 100% (control) to 63.7±3.0, 15.0±2.5
and 2.4±1.1% in the presence of trachylobane-360 and to 87.3±Fig. 2. Cumulative concentration–response curves to histamine in the absence (■) and
presence of trachylobane-360 (A) or trachylobane-318 (B): 3×10−5 (□), 10−4 (●) and
3×10−4 M (○) (n=5). Symbols and vertical bars represent themean and S.E.M…One-
way ANOVA followed by Bonferroni's test, signiﬁcant differences are indicated by
⁎Pb0.05 and ⁎⁎Pb0.001 (control vs. trachylobane-360 or trachylobane-318).
Fig. 3. Cumulative concentration–response curves to CaCl2 in depolarizing medium
nominally without Ca2+ in the absence (■) and presence of trachylobane-360 (A) or
trachylobane-318 (B): 3×10−5 (□), 10−4 (●) and 3×10−4 M (○) (n=5). Symbols
and vertical bars represent the mean and S.E.M. One-way ANOVA followed by Bonfer-
roni's test, signiﬁcant differences are indicated by ⁎Pb0.05 and ⁎⁎Pb0.001 (control vs.
trachylobane-360 or trachylobane-318).4.0, 17.7±3.7 and 3.1±0.5% in the presence of trachylobane-318
which indicates a possible Cav blockade and a [Ca2+]c decrease.
3.3. Effect of trachylobane-360 and trachylobane-318 on S-(-)-Bay
K8644-induced tonic contractions
The cumulative addition of trachylobane-360 (10−7 – 3×10−4 M)
to the tonic component of S-(−)-Bay K8644-induced contraction trig-
gered a concentration-dependent relaxation (Fig. 4A). This effect
(EC50=3.5±0.7×10−5 M) was similar to when the contraction was
elicited with 40 mM KCl (EC50=1.1±0.2×10−5 M). In the same
way, trachylobane-318 signiﬁcantly and concentration-dependently
relaxed the ileum pre-contracted with S-(−)-Bay K8644 (Fig. 4B)
(EC50=5.5±0.3×10−5 M) and with 40 mM KCl (EC50=1.4±
0.2×10−5 M).
3.4. Effect of trachylobane-360 and trachylobane-318 on histamine-induced
tonic contractions in both presence and absence of non-selective potassium
channel blocker (TEA+ 5 mM)
Both diterpenes (10−8 – 3×10−4 M) relaxed ileum pre-contracted
with histamine in presence of TEA+ 5 mM (Fig. 5A and 5B), a non-
selective potassium channel blocker, as can be observed through EC50
values, which in the absence of the blocker were EC50=1.5±0.3 and
0.1±0.01×10−5 M, and in the presence of the blocker were
EC50=0.5±0.04×10−4 M and 2.0±0.5×10−5 M to trachylobane-
360 and trachylobane-318, respectively. The EC50 values of
Fig. 4. Effect of trachylobane-360 (A) and trachylobane-318 (B) on the tonic contrac-
tions induced by 40 mM KCl (▲) or 3×10−7 M S-(−)_Bay K8644 (○) (n=5),
Pb0.05. Symbols and vertical bars represent the mean and S.E.M., respectively.
Fig. 5. Effect of trachylobane-360 (A) and trachylobane-318 (B) on the tonic contrac-
tions induced by histamine in the absence (▼) and presence (△) of TEA+ 5 mM
(n=5), Pb0.05. Symbols and vertical bars represent the mean and S.E.M., respectively.
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and 20 times in the presence of this blocker, respectively.3.5. Effect of trachylobane-360 and trachylobane-318 on histamine-induced
tonic contractions in both presence and absence of selective potassium
channel blockers (glibenclamide, apamin, 4-AP, TEA+ 1 mM or IbTx)
Trachylobane-360 spasmolytic effect (EC50=1.5±0.3×10−5 M)
did not modify statistically in the presence of glibenclamide, a KATP
blocker, (EC50=0.8±0.3×10−5 M); 4-AP, a Kv blocker, (EC50=2.1±
0.7×10−5 M); apamin, a SKca blocker, (EC50=1.2±0.3×10−5 M);
TEA+ 1 mM, a selective BKca blocker, (EC50=1.9±0.7×10−5 M) nor
IbTx, a BKca speciﬁc blocker (EC50=1.1±0.1×10−5 M) (Fig. 6A). Dif-
ferently, trachylobane-318 spasmolytic effect (EC50=0.1±0.01×
10−5 M) was attenuated in the presence of glibenclamide (EC50=1.1±
0.3×10−5 M), 4-AP (EC50=0.7±0.2×10−5 M) and apamin
(EC50=0.7±0.2×10−5 M), but no signiﬁcant variation was observed
in the presence of TEA+ 1mM (EC50=0.4±0.1×10−5 M) nor IbTx
(EC50=0.2±0.07×10−5 M) (Fig. 6B).3.6. Effect of trachylobane-360 and trachylobane-318 on histamine-induced
tonic contractions in both presence and absence of non-selective
phosphodiesterase inhibitor (aminophylline)
Trachylobane-360 and trachylobane-318 relaxation curves
(EC50=1.5±0.3×10−5 M and 0.1±0.01×10−5 M, respectively)
were not signiﬁcantly altered in the presence of aminophylline, a
non-selective phosphodiesterase inhibitor (Fig. 7A and B).3.7. Effect of trachylobane-360 and trachylobane-318 on cytosolic calcium
concentration of myocytes isolated from ileum longitudinal layer
Histamine (10−6 M) induced an increase in the cytosolic calcium
in myocytes from the ileum longitudinal layer loaded with calcium
ﬂuorophore Fluo-4. A biphasical elevation of cytosolic calcium
where the ﬂuorescence peak occurred in 20 seconds after histamine
addition, falling slightly and remaining stable throughout the stimu-
lation (180 seconds) (Fig. 8A). After histamine-induced cytosolic cal-
cium stabilization, trachylobane-360 (3×10−5 M) was added,
reducing the [Ca2+]c (26.6±14.3%) of cells exposure to diterpene in
10 seconds, sustaining this reduction (36.2±13.8%) throughout the
observation period, which indicates a signiﬁcant [Ca2+]c decrease
(Figs. 8B and 9A). In the same way, trachylobane-318 (3×10−5 M)
reduced the [Ca2+]c (56.6±11.7%) in the initial 10 seconds, staying
reduced (69.3±7.9%) throughout the observation period, showing a
signiﬁcant [Ca2+]c decrease (Figs. 8C and 9B).
4. Discussion
In this study we elucidated the spasmolytic action mechanism of
trachylolbane-360 and trachylobane-318 at functional and cellular
levels. We found differences between the action mechanisms,
which probably are due to chemical dissimilarities between them, a
substitution of an acetoxy group (trachylobane-360) for a hydroxyl
(trachylobane-318) in the basic chemical molecule.
Previously, we have demonstrated that both diterpenes presented
spasmolytic activity on tonic and phasic contractions in guinea pig
ileum and this effect occurred more potently for trachylobane-318
than trachylobane-360, circa 15 times, when contractions were eli-
cited by histamine (Santos et al., 2011). Thus, a hypothesis that
Fig. 6. Effect of trachylobane-360 (A) and trachylobane-318 (B) on the tonic contractions
induced by histamine in the absence (■) and presence of glibenclamide (□), 4-AP (Δ),
apamin (∇) TEA+ 1 mM (◊) or iberiotoxin (○) (n=5), Pb0.05. Symbols and vertical
bars represent the mean and S.E.M., respectively.
Fig. 7. Effect of trachylobane-360 (A) and trachylobane-318 (B) on the tonic contrac-
tions induced by histamine in the absence (▼) and presence of aminophylline (□)
(n=5). Symbols and vertical bars represent the mean and S.E.M., respectively.
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gic receptors to promote its spasmolytic effect was assessed. Howev-
er, on histamine-induced cumulative contraction protocols, the
diterpenes showed the pharmacologic proﬁle of noncompetitive
drugs, shifting the histamine cumulative concentration–response
curve nonparallelly to the right with Emax reduction and showing
slope values that differ from the unit, so the competitive antagonism
on histaminergic receptors was refuted.
The ileal smooth muscle is known to present biphasic contraction
where, in the ﬁrst phase, the muscle exhibits a fast and transient con-
traction followed by a long-lasting second phase characterized by the
maintained tonic contraction (Horie et al., 2005; Tanahashi et al.,
2009). However, both phasic and tonic antagonist-induced contractions
depend on extracellular calcium since both are inhibited in its absence
(Honda et al., 1996). The removal of extracellular Ca2+ prevents con-
tractile responses induced by depolarizing agents (electromechanical
coupling), such as KCl, or by agonists of mixed coupling (pharmacome-
chanical and electromechanical), such as carbachol and histamine, in
few seconds, suggesting that the intracellular Ca2+ do not contribute
signiﬁcantly to the tension level (Nouailhetas et al., 1985).
Since the antagonism on histaminergic receptors was discarded
and trachylobane-360 and trachylobane-318 exerted spasmolytic ac-
tion in guinea pig ileum contracted by KCl, carbachol or histamine,
another relevant hypothesis is that of an action on a common path-
way related to the cascade of events elicited by these agents that
leads to smooth muscle contraction: the Ca2+ inﬂux through Cav.
Thus, CaCl2-induced contractions in depolarizing nominally Ca2+-
free medium were used to assess the possible Cav blockade by diter-
penes. This protocol is based on the fact that contraction will beobtained almost exclusively by Ca2+ from extracellular medium,
since depolarization promoted by elevated extracellular potassium
concentrations leads to Cav opening (Rembold, 1992). Both com-
pounds inhibited signiﬁcantly CaCl2-induced contractions, shifting
them to the right and reducing Emax, reinforcing the hypothesis of cal-
cium inﬂux blockade on trachylobane-360 and trachylobane-318
spasmolytic effect.
In smooth muscle, Cav1 are the main responsible to calcium inﬂux.
These channels are subdivided as Cav1.1, Cav1.2, Cav1.3 and Cav1.4
and are sensitive to dihydropyridine and high voltage (Alexander
et al., 2008). Cav are composed by 4 subunits (2 α, 1 β and 1 γ)
where α1 forms the pore that leads calcium inﬂux (Kuriyama et al.,
1995). Thus, the next step was to conﬁrm and identify the Cav subtype
involved on diterpenes spasmolytic activity. Therefore, tonic contrac-
tions were obtained using S-(-)-Bay K8644, a speciﬁc dihydropyridine
derivative agonist for Cav1 that binds directly withα1-subunit to open
these channels, but not by depolarization (Spedding and Paoletti,
1992). Both trachylobanes equipotently and signiﬁcantly relaxed the
ileum pre-contracted with S-(-)-Bay K8644 and in comparison to the
relaxant effect on KCl-contracted ileum, an electromechanical agent
that activates Cav to promote contraction, no signiﬁcant difference
was observed. Furthermore, as the more expressive Cav subtype in
ileum is Cav1.2 (Catterall et al., 2005), we conﬁrm that the calcium in-
ﬂux blockade through Cav1.2 is implicated in the mechanism of spas-
molytic action of trachylobane-360 and trachylobane-318 on guinea
pig ileum.
Potassium channels play a key role in the regulation of membrane
potential and cellular excitability since the contraction of smooth
muscle dependents on the balance between increased K+ ion conduc-
tance, leading to hyperpolarization/repolarization, and reduced K+
Fig. 8. Representative original records of control (A), trachylobane-360 (B) and trachylobane-318 (C) effects under the sign of calcium in myocytes from the longitudinal layer of
guinea pig ileum stimulated with histamine and loaded with Fluo-4.
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2000), and the K+ movement across the membrane regulates Ca2+
inﬂux through Cav (Thorneloe and Nelson, 2005). We observed that
both diterpenes relaxed guinea pig ileum by blocking calcium chan-
nels, but this may be through an indirect effect, the activation of po-
tassium channels. Hence, the trachylobanes effect on guinea pig
ileum was assessed with TEA+ 5 mM, a non-selective K+ channels
blocker. In the presence of TEA+, trachylobane-360 and
trachylobane-318-induced relaxation curves were shifted to the
right (3 and 20 times), indicating the participation of K+ channels
on the spasmolytic effect of both trachylobanes.
Several K+ channel subtypes are present in smooth muscle, such
as KATP (Teramoto, 2006), Kv (Gordienko et al., 1999), SKca, IKca, BKca
(Wei et al., 2005). All of them show regulation and operation partic-
ularities but, in general, they act regulating membrane excitability
and contribute to the contraction and relaxation processes of smooth
muscle. Thus, as a positive modulation of K+ channels was observed
on trachylobane-360 and trachylobane-318 spasmolytic effect, we
decided to investigate which K+ channel subtypes (KATP, Kv, SKca, or
BKca) might be involved in this effect. For that, the aforementioned
speciﬁc K+ channel blockers were used and, interestingly, different
results were found. Trachylobane-360 did not seem to modulate any
of the four studied potassium channel subtypes. However, aspreviously described, we evidenced that the diterpene non-
speciﬁcally modulated K+ channels and these diverging results can
be explained by the fact that trachylobane-360 may be acting on
other not studied K+ channel subtypes such as inwardly rectifying
K+ channels (Kir) or intermediate-conductance calcium-activated
K+ channels (IKCa). On the other hand, trachylobane-318 modulated
positively KATP, KV and SKCa, but not BKCa, and that would hyperpolar-
ize/repolarize the plasmatic membrane inactivating Ca2+ channels
and allowing the ileum to relax. The main reason for the observed dif-
ferences in modulation manner of both trachylobanes on the studied
K+ channel subtypes is possibly due to the chemical dissimilarity be-
tween them. The hydroxyl group being present in position 7 of
trachylobane-318 structure and absent in trachylobane-360 might
allow this K+ current modulation and contributes to the KATP, KV
and SKCa participation on the spasmolytic effect of this diterpene.
Cyclic nucleotides phosphodiesterases (PDEs) are widely distrib-
uted in mammal tissues and are responsible for cAMP and cGMP hy-
drolysis, resulting in their inactive products 5′-AMP and 5′-GMP,
which do not activate PKA and PKG, respectively, thus stopping the
cell signaling mechanism dependent on cyclic nucleotides increase
(Lugnier, 2006). Substances capable to raise the intracellular content
of cAMP or cGMP show a potentiated relaxant effect through PDE in-
hibition in different tissues due to an increase in the total content of
Fig. 9. Effect of trachylobane-360 (A) and trachylobane-318 (B) on the ﬂuorescence in-
duced by histamine in guinea pig ileum myocytes (n=3). Columns and vertical bars
represent the mean and S.E.M., respectively. t-test; *Pb0.05 (histamine vs.
trachylobane-360 or trachylobane-318).
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(Bender and Beavo, 2006). Therefore, in order to verify if
trachylobane-360 or trachylobane-318 can alter the intracellular con-
tent of cyclic nucleotides, the relaxant effect of diterpenes was
assayed in the presence of aminophylline, a non-selective phosphodi-
esterase inhibitor. The presence of aminophylline did not alter
trachylobane-360 or trachylobane-318 spasmolytic activity in guinea
pig ileum, suggesting that cyclic nucleotides are not involved in their
action mechanism.
To relax smooth muscle it required a reduction of [Ca2+]c, since
contraction triggers and part of contraction maintenance depends
on [Ca2+]c increase (Somlyo and Somlyo, 1994; Webb, 2003). Nowa-
days, techniques that use ﬂuorescent indicators allow us to measure
the cytosolic calcium concentration in several models of smooth mus-
cles (Wray et al., 2005). Hitherto, the spasmolytic action mechanism
of both compounds theoretically reduces [Ca2+]c availability through
Ca2+ channel blockade and K+ channel activation, but no evidence of
this has been shown. Thus, we aimed to provide evidence of [Ca2+]c
reduction by trachylobane-360 and trachylobane-318 in myocytes
isolated from ileum longitudinal layer and, so, better characterize
their action mechanism. Fluo-4, a ﬂuorescent indicator of calcium,
was added to the preparations containing ileummyocytes and the re-
sultant ﬂuorescence was quantiﬁed in the presence of each diterpene.
Both trachylobane-360 and trachylobane-318 similarly reduced the
great ﬂuorescence emitted in the presence of histamine, which indi-
cates [Ca2+]c reduction. These results in cellular experiments support
our ﬁndings in functional level and evidence that both trachylobanes
reduce [Ca2+]c to play their spasmolytic role. Furthermore, chemical
differences between them, or differences in their action mechanisms,did not interfere or alter their ability to reduce [Ca2+]c since the re-
duction was equipotent.
In conclusion, this study shows that both trachylobane-360 and
trachylobane-318 exert their spasmolytic effect on guinea pig ileum
through a blockade of Ca2+ channels and that the channel subtype
involved is Cav 1.2. Furthermore, both diterpenes modulate K+
channels positively, though in different ways. Trachylobane-360
seems to act in other K+ channels subtypes not studied in our
experiments, while trachylobane-318 seems to activate KATP, KV and
SKCa but different subtypes are not discarded of participating in its
spasmolytic activity. In addition, the elevation of cyclic nucleotide
content is not involved in the effect of any of the studied diterpenes.
It is now established that, in cellular experiments, trachylobane-360
and trachylobane-318 decrease [Ca2+]c to promote the spasmolytic
activity observed in tissue experiments.
Acknowledgements
The authors thank CAPES, CNPq and FAPESQ-PB for the ﬁnancial
support, UNIFESP for the experimental support and José Crispim
Duarte for providing technical assistance.
References
Aboulaﬁa, J., Silva, B.A., Nouailhetas, V.L.A., 2002. Protein kinase C modulators enhance
angiotensin II desensitization of guinea-pig ileum via maxi-K+ channels. Eur. J.
Pharmacol. 442, 29–36.
Alexander, S.P.H., Mathie, A., Peters, J.A., 2008. Guide to receptors and channels
(GRAC), 3rd edition. Br. J. Pharmacol. 153 (Suppl 2), S1–S209.
Bender, A.T., Beavo, J.A., 2006. Cyclic nucleotide phosphodiesterases: molecular regula-
tion to clinical use. Pharmacol. Rev. 58, 488–520.
Campos de Andrade, N., Barbosa-Filho, J.M., Da-Silva, M.S., da-Cunha, E.V.L., Maia, J.G.S.,
2004. Diterpenes and volatile constituents from the leaves of Xylopia cayennensis
Maas. Biochem. Syst. Ecol. 32, 1055–1058.
Castello-Branco, M.V.S., Anazetti, M.C., Silva, M.S., Tavares, J.F., Diniz, M.F.F.M.,
Frungillo, L., Haun, M., Melo, P.S., 2009. Diterpenes from Xylopia langsdorfﬁana
inhibit cell growth and induce differentiation in human leukemia cells. Z. Natur-
forsch., C: Biosci. 64, 650–656.
Catterall, W.A., Perez-Reyes, E., Snutch, T.P., Striessnig, J., 2005. International Union of
Pharmacology. XLVIII. Nomenclature and structure–function relationships of
voltage-gated calcium channels. Pharmacol. Rev. 57, 411–425.
Chamley-Campbell, J., Campbell, G.R., Ross, R., 1979. The smooth muscle cell in culture.
Physiol. Rev. 59, 1–61.
Dunne, A., 1979. Comparison of individual and cumulative dose–response curves
[proceedings]. Br. J. Pharmacol. 67, 491–492.
Ferrante, J., Luchowski, E., Rutledge, A., Triggle, D.J., 1989. Binding of A 1,4-dihydropyr-
idine calcium channel activator, (−)-S-BayK 8644, to cardiac preparations.
Biochem. Biophys. Res. Commun. 158, 149–154.
Gordienko, D.V., Zholos, A.V., Bolton, T.B., 1999. Membrane ion channels as physiolog-
ical targets for local Ca2+ signalling. J. Microsc. 196, 305–316.
Hirsh, L., Dantes, A., Suh, B.-S., Yoshida, Y., Hosokawa, K., Tajima, K., Kotsuji, F.,
Merimsky, O., Amsterdam, A., 2004. Phosphodiesterase inhibitors as anti-cancer
drugs. Biochem. Pharmacol. 68, 981–988.
Honda, K., Takano, Y., Kamiya, H., 1996. Involvement of protein kinase C in muscarinic
agonist-induced contractions of guinea pig ileal longitudinal muscle. Gen. Pharmacol.
27, 957–961.
Horie, S., Tsurumaki, Y., Someya, A., Hirabayashi, T., Saito, T., Okuma, Y., Nomura, Y.,
Murayama, T., 2005. Involvement of cyclooxygenase-dependent pathway in
contraction of isolated ileum by urotensin II. Peptides 26, 323–329.
Ishii, T.M., Maylie, J., Adelman, J.P., 1997. Determinants of apamin and d-tubocurarine
block in SK potassium channels. J. Biol. Chem. 272, 23195–23200.
Knot, H.T., Brayden, E.J., Nelson, M.T., 1996. Calcium channels and potassium channels.
In: Bárány, M. (Ed.), Biochemistry of Smooth Muscle Contraction. Academic Press,
San Diego, USA, pp. 203–219.
Kuriyama, H., Kitamura, K., Nabata, H., 1995. Pharmacological and physiological signiﬁ-
cance of ion channels and factors that modulate them in vascular tissues. Pharmacol.
Rev. 47, 387–573.
Latorre, R., Oberhauser, A., Labarca, P., Alvarez, O., 1989. Varieties of calcium-activated
potassium channels. Annu. Rev. Physiol. 51, 385–399.
Lee, S.W., 2000. Physiological roles and properties of potassium channels in corporal
smooth muscle. Drugs Today 36, 147–154.
Li, C., Lee, D., Graf, T.N., Phifer, S.S., Nakanishi, Y., Burgess, J.P., Riswan, S., Setyowati, F.M.,
Saribi, A.M., Soejarto, D.D., Farnsworth, N.R., Falkinham, J.O., Kroll, D.J., Kinghorn, A.D.,
Wani, M.C., Oberlies, N.H., 2005. A hexacyclic ent-trachylobane diterpenoid
possessing an oxetane ring fromMitrephora glabra. Org. Lett. 7, 5709–5712.
Lima, M.R.F., De Ximenes, E.C.P.A., Luna, J.S., Sant'Ana, A.E.G., 2006. The antibiotic
activity of some Brazilian medicinal plants. Braz. J. Pharmacog. 16, 300–306.
Lugnier, C., 2006. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target
for the development of speciﬁc therapeutic agents. Pharmacol. Ther. 109, 366–398.
47R.F. Santos et al. / European Journal of Pharmacology 678 (2012) 39–47Martinsen, A., Baccelli, C., Navarro, I., Abad, A., Quetin-Leclercq, J., Morel, N., 2010.
Vascular activity of a natural diterpene isolated from Croton zambesicus and of a
structurally similar synthetic trachylobane. Vascul. Pharmacol. 52, 63–69.
McChesney, J.D., Venkataraman, S.K., Henri, J.T., 2007. Plant natural products: back to
the future or into extinction? Phytochemistry 68, 2015–2022.
Moreira, I.C., Roque, N.F., Contini, K., Lago, J.H.G., 2007. Sesquiterpenes and hydrocar-
bons from Xylopia emarginata (Annonaceae) fruits. Braz. J. Pharmacog. 17, 55–58.
Nascimento, A.A., Ribeiro, Ê.A.N., Oliveira, J.M., Medeiros, F.A., Silva, M.S., Medeiros, I.A.,
2006. Cardiovascular effects induced by the hydroalcoholic extract of the stem of
Xylopia cayennensis in rats. Braz. J. Pharmacog. 16, 17–21.
Neubig, R.R., Spedding, M., Kenakin, T., Christopoulos, A., 2003. International Union of
Pharmacology Committee on Receptor Nomenclature and Drug Classiﬁcation.
XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol.
Rev. 55, 597–606.
Nouailhetas, V.L., Shimuta, S.I., Paiva, A.C., Paiva, T.B., 1985. Calcium and sodium depen-
dence of the biphasic response of the guinea-pig ileum to agonists. Eur. J. Pharma-
col. 116, 41–47.
Oliveira, A.P., Furtado, F.F., da Silva, M.S., Tavares, J.F., Mafra, R.A., Araújo, D.A.M., Cruz, J.S.,
de Medeiros, I.A., 2006. Calcium channel blockade as a target for the cardiovascular
effects induced by the 8 (17), 12E, 14-labdatrien-18-oic acid (labdane-302). Vascul.
Pharmacol. 44, 338–344.
Pan, L., Zhou, P., Zhang, X., Peng, S., Ding, L., Qiu, S.X., 2006. Skeleton-rearranged
pentacyclic diterpenoids possessing a cyclobutane ring from Euphorbia wallichii.
Org. Lett. 8, 2775–2778.
Paredes, R.M., Etzler, J.C., Watts, L.T., Zheng, W., Lechleiter, J.D., 2008. Chemical calcium
indicators. Methods 46, 143–151.
Rembold, C.M., 1992. Regulation of contraction and relaxation in arterial smooth
muscle. Hypertension 20, 129–137.
Ribeiro, L.A.A., Tavares, J.F., de Andrade, N.C., da Silva, M.S., da Silva, B.A., 2007. The (8)
17,12E,14-labdatrien-18-oic acid (labdane302), labdane-type diterpene isolated
from Xylopia langsdorfﬁana St. Hil. & Tul. (Annonaceae) relaxes the guinea-pig
trachea. Braz. J. Pharmacog. 17, 197–203.
Robertson, B.E., Nelson, M.T., 1994. Aminopyridine inhibition and voltage dependence
of K+ currents in smooth muscle cells from cerebral arteries. Am. J. Physiol. 267,
1589–1597.
Santos R.F., Martins I.R.R., Monteiro F.S., Travassos R.A., Janebro D.I., Tavares J.F., Silva
M.S., Silva B.A., in press. Spasmolytic activity of trachylobanes ent-7α-acetoxytra-
chyloban-18-oic acid and ent-7α-hydroxytrachyloban-18-oic acid isolated from
Xylopia langsdorﬁana A. St-Hil. & Tul (Annonaceae). Nat. Prod. Res. 25.Silva, M.S., Tavares, J.F., Queiroga, K.F., Agra, M.F., Barbosa Filho, J.M., 2009. Alkaloids
and other constituents from Xylopia langsdorfﬁana (Annonaceae). Quím. Nova 32,
1566–1570.
Somlyo, A.P., Somlyo, A.V., 1994. Signal transduction and regulation in smooth muscle.
Nature 372, 231–236.
Spedding, M., Paoletti, R., 1992. Classiﬁcation of calcium channels and the sites of
action of drugs modifying channel function. Pharmacol. Rev. 44, 363–376.
Sun, Y.D., Benishin, C.G., 1994. K+ channel openers relax longitudinal muscle of guinea
pig ileum. Eur. J. Pharmacol. 271, 453–459.
Takahashi, J.A., Pereira, C.R., Pimenta, L.P.S., Boaventura, M.A.D., Silva, L.G.F.E., 2006.
Antibacterial activity of eight Brazilian annonaceae plants. Nat. Prod. Res. 20,
21–26.
Tanahashi, Y., Unno, T., Matsuyama, H., Ishii, T., Yamada, M., Wess, J., Komori, S., 2009.
Multiple muscarinic pathways mediate the suppression of voltage-gated Ca2+
channels in mouse intestinal smooth muscle cells. Br. J. Pharmacol. 158,
1874–1883.
Tavares, J.F., Queiroga, K.F., Silva, M.V.B., Diniz, M.F.F.M., Filho, J.M.B., Cunha, E.V.L.,
Simone, C.A. de Júnior, J.X., de A., Melo, P.S., Haun, M., Silva, M.S., 2006. ent-trachy-
lobane diterpenoids from Xylopia langsdorfﬁana. J. Nat. Prod. 69, 960–962 da.
Teramoto, N., 2006. Physiological roles of ATP-sensitive K+ channels in smooth muscle.
J. Physiol. (Lond.) 572, 617–624.
Thorneloe, K.S., Nelson, M.T., 2005. Ion channels in smooth muscle: regulators of intra-
cellular calcium and contractility. Can. J. Physiol. Pharmacol. 83, 215–242.
Usowicz, M.M., Gigg, M., Jones, L.M., Cheung, C.W., Hartley, S.A., 1995. Allosteric inter-
actions at L-type calcium channels between FPL 64176 and the enantiomers of the
dihydropyridine Bay K 8644. J. Pharmacol. Exp. Ther. 275, 638–645.
Vega, M.R.G., Esteves-Souza, A., Vieira, I.J.C., Mathias, L., Braz-Filho, R., Echevarria, A.,
2007. Flavonoids from Annona dioica leaves and their effects in Ehrlich carcinoma
cells, DNA-topoisomerase I and II. J. Braz. Chem. Soc. 18, 1554–1559.
Webb, R.C., 2003. Smooth muscle contraction and relaxation. Adv. Physiol. Educ. 27,
201–206.
Wei, A.D., Gutman, G.A., Aldrich, R., Chandy, K.G., Grissmer, S., Wulff, H., 2005. Interna-
tional Union of Pharmacology. LII. Nomenclature and molecular relationships of
calcium-activated potassium channels. Pharmacol. Rev. 57, 463–472.
Wray, S., Burdyga, T., Noble, K., 2005. Calcium signalling in smooth muscle. Cell
Calcium 38, 397–407.
